Mark W. Sawicki's Insider Trades & SAST Disclosures
Mark W. Sawicki's most recent trade in CryoPort Inc was a trade of 1,349 Common Stock done at an average price of $6.9 . Disclosure was reported to the exchange on March 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark W. Sawicki.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.94 per share. | 24 Mar 2025 | 1,349 | 84,087 (0%) | 0% | 6.9 | 9,364 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 9,000 | 87,528 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 14 Mar 2025 | 2,092 | 85,436 (0%) | 0% | 6.3 | 13,162 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 2,667 | 80,111 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 2,667 | 0 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.88 per share. | 09 Mar 2025 | 1,583 | 78,528 (0%) | 0% | 4.9 | 7,724 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.54 per share. | 25 Mar 2024 | 1,367 | 77,444 (0%) | 0% | 17.5 | 23,980 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2024 | 11,500 | 11,500 | - | - | Stock Option (right to buy) | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2024 | 5,750 | 78,811 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 2,666 | 75,791 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 2,666 | 2,667 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.35 per share. | 09 Mar 2024 | 1,418 | 74,373 (0%) | 0% | 16.4 | 23,188 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.43 per share. | 09 Mar 2024 | 1,312 | 73,061 (0%) | 0% | 15.4 | 20,247 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2023 | 20,910 | 20,910 | - | - | Stock Option (right to buy) | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2023 | 10,455 | 72,125 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.79 per share. | 15 Mar 2023 | 1,362 | 61,670 (0%) | 0% | 20.8 | 28,316 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 2,667 | 64,508 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 2,667 | 5,333 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.14 per share. | 09 Mar 2023 | 1,476 | 63,032 (0%) | 0% | 20.1 | 29,727 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 20,910 | 20,910 | - | - | Stock Option (right to buy) | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 10,455 | 61,841 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 2,667 | 8,000 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 2,667 | 52,796 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 09 Mar 2022 | 1,410 | 51,386 (0%) | 0% | 31.1 | 43,781 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 11 Aug 2021 | 77,625 | 113,698 (0%) | 0% | 7.8 | 605,475 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 77,625 | 0 | - | - | Option to purchase common stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 58.37 per share. | 11 Aug 2021 | 74,453 | 55,822 (0%) | 0% | 58.4 | 4,346,119 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.65 per share. | 11 Aug 2021 | 16,577 | 130,275 (0%) | 0% | 8.6 | 143,391 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 16,577 | 51,423 | - | - | Option to purchase common stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 59.11 per share. | 11 Aug 2021 | 3,172 | 52,650 (0%) | 0% | 59.1 | 187,512 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 59.83 per share. | 11 Aug 2021 | 2,521 | 50,129 (0%) | 0% | 59.8 | 150,841 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 21,333 | 21,333 | - | - | Option to purchase common stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 11,831 | 0 | - | - | Options to purchase common stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.21 per share. | 09 Mar 2021 | 11,831 | 49,404 (0%) | 0% | 3.2 | 37,978 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 11,342 | 0 | - | - | Options to purchase common stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. | 09 Mar 2021 | 11,342 | 30,342 (0%) | 0% | 3.1 | 34,820 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 10,667 | 10,667 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.33 per share. | 09 Mar 2021 | 9,357 | 36,073 (0%) | 0% | 55.3 | 517,768 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 09 Mar 2021 | 7,231 | 37,573 (0%) | 0% | 1.9 | 13,522 | Common Stock |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 7,231 | 0 | - | - | Options to purchase common stock | |
| CryoPort Inc | Mark W. Sawicki | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 54.65 per share. | 09 Mar 2021 | 3,974 | 45,430 (0%) | 0% | 54.6 | 217,166 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges